| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 168.53▲ | 168.17▲ | 168.22▲ | 165.23▲ | 160.04▲ |
| MA10 | 168.46▲ | 168.16▲ | 169.29▼ | 162.47▲ | 169.58▼ |
| MA20 | 168.21▲ | 169.96▼ | 170.07▼ | 161.19▲ | 165.51▲ |
| MA50 | 168.33▲ | 167.76▲ | 164.51▲ | 171.88▼ | 134.93▲ |
| MA100 | 169.50▼ | 163.95▲ | 161.02▲ | 163.59▲ | 114.43▲ |
| MA200 | 170.42▼ | 160.61▲ | 162.18▲ | 139.73▲ | 90.57▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.053▲ | -0.367▼ | -0.694▼ | 1.919▲ | -3.373▼ |
| RSI | 57.077▲ | 48.538▼ | 53.793▲ | 54.483▲ | 58.922▲ |
| STOCH | 56.093 | 39.363 | 18.588▼ | 71.039 | 19.556▼ |
| WILL %R | -16.923▲ | -65.052 | -74.907 | -27.985 | -53.027 |
| CCI | 67.689 | -20.272 | -60.799 | 132.279▲ | -45.314 |
|
Saturday, April 04, 2026 12:10 PM
Based on Axsome Therapeutics’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $196 million and a GAAP net loss of $28.56 million. In comparison, ...
|
|
Wednesday, April 01, 2026 07:02 AM
Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitor Acquisition further expands Axsome’s industry-leading CNS portfolio with a ...
|
|
Tuesday, February 24, 2026 09:08 AM
Axsome Therapeutics AXSM incurred a loss of 71 cents per share in the fourth quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 70 cents. The company had incurred a loss of 96 cents ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 171.22 | 171.22 | 166.75 | 168.505 | 525,975 |
| 01/04/26 | 170.48 | 174.81 | 169.875 | 171.78 | 581,084 |
| 31/03/26 | 160.20 | 171.60 | 159.92 | 169.02 | 669,188 |
| 30/03/26 | 155.75 | 160.97 | 155.00 | 160.50 | 504,419 |
| 27/03/26 | 163.89 | 163.89 | 155.5601 | 156.35 | 661,653 |
| 26/03/26 | 160.05 | 165.69 | 159.055 | 164.265 | 297,778 |
| 25/03/26 | 160.60 | 163.48 | 160.60 | 161.78 | 434,869 |
| 24/03/26 | 155.90 | 158.96 | 152.28 | 158.75 | 1,251,779 |
| 23/03/26 | 156.98 | 159.40 | 153.46 | 156.84 | 378,201 |
| 20/03/26 | 159.64 | 160.03 | 155.42 | 156.92 | 802,076 |
|
|
||||
|
|
||||
|
|